Market Cap | ₹595Cr |
ROE | 13.20% |
P/E Ratio(TTM) | 21.23 |
EPS(TTM) | 16.02 |
P/B Ratio | 2.36 |
Dividend Yield | 0.00% |
Industry P/E | 33.86 |
Book Value | 144.30 |
Debt to Equity | 0.24 |
Face Value | 10 |
Parent Organisation | Kilitch Drugs (india) Limited. |
Managing Director | Mr. Mukund Mehta |
NSE Symbol | KILITCH |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 60.60 | ||
Gland Pharma | NA (0.00%) | 43.02 | ||
Ajanta Pharma | NA (0.00%) | 32.53 | ||
Eris Lifesciences | NA (0.00%) | 55.50 |